Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

The molecular classification of endometroid ovarian carcinomas (EnOC) has not been established, preventing the development of stratified therapeutic approaches. Here the authors characterise the molecular landscape of EnOC by whole exome sequencing, identifying clinically distinct disease subtypes.

Guardado en:
Detalles Bibliográficos
Autores principales: Robert L. Hollis, John P. Thomson, Barbara Stanley, Michael Churchman, Alison M. Meynert, Tzyvia Rye, Clare Bartos, Yasushi Iida, Ian Croy, Melanie Mackean, Fiona Nussey, Aikou Okamoto, Colin A. Semple, Charlie Gourley, C. Simon Herrington
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/232b42338ac04ca39f011da44d0890a8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:232b42338ac04ca39f011da44d0890a8
record_format dspace
spelling oai:doaj.org-article:232b42338ac04ca39f011da44d0890a82021-12-02T19:16:29ZMolecular stratification of endometrioid ovarian carcinoma predicts clinical outcome10.1038/s41467-020-18819-52041-1723https://doaj.org/article/232b42338ac04ca39f011da44d0890a82020-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-18819-5https://doaj.org/toc/2041-1723The molecular classification of endometroid ovarian carcinomas (EnOC) has not been established, preventing the development of stratified therapeutic approaches. Here the authors characterise the molecular landscape of EnOC by whole exome sequencing, identifying clinically distinct disease subtypes.Robert L. HollisJohn P. ThomsonBarbara StanleyMichael ChurchmanAlison M. MeynertTzyvia RyeClare BartosYasushi IidaIan CroyMelanie MackeanFiona NusseyAikou OkamotoColin A. SempleCharlie GourleyC. Simon HerringtonNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Robert L. Hollis
John P. Thomson
Barbara Stanley
Michael Churchman
Alison M. Meynert
Tzyvia Rye
Clare Bartos
Yasushi Iida
Ian Croy
Melanie Mackean
Fiona Nussey
Aikou Okamoto
Colin A. Semple
Charlie Gourley
C. Simon Herrington
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
description The molecular classification of endometroid ovarian carcinomas (EnOC) has not been established, preventing the development of stratified therapeutic approaches. Here the authors characterise the molecular landscape of EnOC by whole exome sequencing, identifying clinically distinct disease subtypes.
format article
author Robert L. Hollis
John P. Thomson
Barbara Stanley
Michael Churchman
Alison M. Meynert
Tzyvia Rye
Clare Bartos
Yasushi Iida
Ian Croy
Melanie Mackean
Fiona Nussey
Aikou Okamoto
Colin A. Semple
Charlie Gourley
C. Simon Herrington
author_facet Robert L. Hollis
John P. Thomson
Barbara Stanley
Michael Churchman
Alison M. Meynert
Tzyvia Rye
Clare Bartos
Yasushi Iida
Ian Croy
Melanie Mackean
Fiona Nussey
Aikou Okamoto
Colin A. Semple
Charlie Gourley
C. Simon Herrington
author_sort Robert L. Hollis
title Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
title_short Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
title_full Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
title_fullStr Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
title_full_unstemmed Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
title_sort molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/232b42338ac04ca39f011da44d0890a8
work_keys_str_mv AT robertlhollis molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT johnpthomson molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT barbarastanley molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT michaelchurchman molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT alisonmmeynert molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT tzyviarye molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT clarebartos molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT yasushiiida molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT iancroy molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT melaniemackean molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT fionanussey molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT aikouokamoto molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT colinasemple molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT charliegourley molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
AT csimonherrington molecularstratificationofendometrioidovariancarcinomapredictsclinicaloutcome
_version_ 1718376901641240576